AI expert XUND GmbH bags 6m seed financing
Austrian XUND GmbH wants to use the assets of a 6m seed financing to grow in Germany, Switzerland and Austria.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1162 entries already.
Entries by Thomas Gabrielczyk
ADC makeer Pheon Therapeutics raises $68m
/in News/by Thomas GabrielczykAntibody-Drug Conjugate (ADC) specialist Pheon Therapeutics Ltd. has closed a $68m Series A financing co-led by Brandon Capital, Forbion and Atlas Venture.
Kupando raises 13m to push TLR4/7 agonist
/in News/by Thomas GabrielczykKupando has raised 13m in Series A financing co-led by Remiges Ventures and LifeCare Partners to initiate clinical development of KUP101.
DAMAN P/S enters personal RA medicine project
/in News/by Thomas GabrielczykDanish AI health app developer DAMAN P/S has entered the 12m EU-funded Squeeze project, that aims to find stratification biomarkers for DMARDs in rheumatoid arthritis (RA).
AI specialist Quinten Health bags 14m financing
/in News/by Thomas GabrielczykQuinten Groups French healthcare arm Quinten Health has closed a financing round to advance disease modeling platforms and virtual twins in real-world.
Bavarian Nordic expands vaccine contract by $234m
/in News/by Thomas GabrielczykBavarian Nordic A/S has expand its smallpox contract signed with the Canadian PHAC in June from $56m to $470m including $180m in contract options.
Food specialist Standing Ovation SA raises 12m
/in News/by Thomas GabrielczykFoodtech startup Standing Ovation SA has closed an oversubscribed 12m Series A financing round led by Astanor Ventures.
HeartBeat.bio inks partnership with Molecular Devices
/in News/by Thomas GabrielczykHeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput drug discovery screening
Mobile app recognises COVID-19 infection
/in News/by Thomas GabrielczykDutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings.
Pleco Therapeutics raises 17.3m in Series A
/in News/by Thomas GabrielczykDutch Pleco Therapeutics BV has raised 17.3m in a Series A financing to push its lead candidate in acute myeloid leukaemia to market approval.